The top 10 biopharma stock gainers and losers for the week.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Momentis.

Year-to-date money raised in public, private and other financings of biopharma companies.

These graphs compare the performance of the biotech stocks for all of 2024 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2024.

Biopharma money raised to-date and by month in 2023, including public, private and other financings.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations:  Altimmune, Arthex, Cumberland, Lakeshore, Mustang, Rapport.

Biopharmas raising money in public or private financings, including: Drugs Made in America, Geron, Ocugen, Sonnet.

New hires and promotions in the biopharma industry, including: Novocure.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: ADC Therapeutics, Aditum, Arctic Vision, Emergent, Leads, Clearside, Santen, Sarepta, Viracta.